An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55–64 and 65+ with aortic stenosis in the UK
Open Access
- 28 August 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 23 (9) , 1087-1099
Abstract
Exploratory analysis to conceptualize and evaluate the potential cost-effectiveness and economic drivers of using a novel tissue valve compared with mechanical heart valves for surgical aortic valve replacement (SAVR) in people aged 55-64 and 65+ with aortic stenosis (AS) from a National Health Service (NHS) UK perspective. A decision-analytic model was developed using a partitioned survival model. Parameter inputs were obtained from published literature. Deterministic and probabilistic sensitivity analyses (DSA and PSA) were conducted to explore the uncertainty around the parameters. The novel tissue valve was potentially associated with higher quality-adjusted life years (QALYs) of 0.01 per person. Potential cost savings were greatest for those aged 55-64 (£408) versus those aged 65+(£53). DSA indicated the results to be most dependent on relative differences in general mortality, procedure costs, and reoperation rates. PSA estimated around 75% of the iterations to be cost-effective at £20,000 per QALY for those aged 55-64, and 57% for those aged 65+. The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.Keywords
Funding Information
- Edwards Lifesciences
This publication has 50 references indexed in Scilit:
- EVEREST II high risk study based UK cost-effectiveness analysis of MitraClip® in patients with severe mitral regurgitation ineligible for conventional repair/replacement surgeryJournal of Medical Economics, 2013
- Long-Term Safety and Effectiveness of Mechanical Versus Biologic Aortic Valve Prostheses in Older PatientsCirculation, 2013
- The evolving epidemiology of valvular aortic stenosis. The Tromsø StudyHeart, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart FailureJournal of Public Health, 2011
- Catalogue of EQ-5D Scores for the United KingdomMedical Decision Making, 2011
- Cost-effectiveness of homograft heart valve replacement surgery: an introductory studyCell and Tissue Banking, 2009
- Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health OutcomeMedical Decision Making, 2009
- Choice of Prosthetic Heart Valve in Today’s PracticeCirculation, 2008
- Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and PreventionThe Annals of Thoracic Surgery, 2005